The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R03 | Drugs for obstructive airway diseases | |
| 3 | R03B | Other drugs for obstructive airway diseases, inhalants | |
| 4 | R03BC | Antiallergic agents, excl. corticosteroids |
| Code | Title | |
|---|---|---|
| R03BC01 | Cromoglicic acid | |
| R03BC03 | Nedocromil |
| Active Ingredient | Description | |
|---|---|---|
| Cromoglicic acid |
Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils. |
|
| Nedocromil |
Nedocromil is a non-steroidal agent, which has anti-inflammatory properties when administered topically in the lung. In the treatment of bronchial asthma, nedocromil sodium reduces bronchospasm, cough and bronchial hyperreactivity and improves objective measurements of lung function. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| INTAL CFC-FREE Pressurised inhalation, suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| NALCROM Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| TILADE Pressurised inhalation suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
